Literature DB >> 26808578

A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.

Ziyu Fang1, Chen Xu2, Yaoming Li1, Xiaobing Cai3, Shancheng Ren1, Houqi Liu4, Yue Wang4, Fubo Wang1, Rui Chen1, Min Qu1, Yang Wang5, Yasheng Zhu1, Wei Zhang1, Xiaolei Shi1, Jingjing Yao1, Xu Gao1, Jianguo Hou1, Chuanliang Xu1, Yinghao Sun6.   

Abstract

We previously reported that PlncRNA-1, a long non-coding RNA that is up-regulated in prostate cancer (PCa), affects the proliferation and apoptosis of PCa cells. However, the molecular mechanisms underlying these effects remain largely unknown. In this study, we demonstrated that long non-coding RNA PlncRNA-1, whose expression is promoted by Androgen Receptor (AR), protects AR from microRNA-mediated suppression in PCa cells. PlncRNA-1 knockdown resulted in the up-regulation of a series of AR-targeting microRNAs, among which miR-34c and miR-297 were found to regulate both AR and PlncRNA-1 expression at the post-transcriptional level. Functional analysis revealed that miR-34c and miR-297 overexpression down-regulated AR expression and inhibited the expression of downstream AR targets and that PlncRNA-1 overexpression rescued these effects. The association of PlncRNA-1 with tumor progression was also evaluated in mouse xenograft models, PCa tissues (16 paired samples), and blood samples (35 biopsy-negative and 37 biopsy-positive). Together, the data generated in this study indicate that PlncRNA-1 sponges AR-targeting microRNAs to protect AR from microRNA-mediated down-regulation and that these events form a regulatory feed-forward loop in the development of PCa. These findings suggest that PlncRNA-1 might potentially serve as a novel biomarker in PCa and that PlncRNA-1 might warrant further investigation to determine its potential role as a promising therapeutic target in PCa.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Long non-coding RNA; PlncRNA-1; Prostate cancer; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26808578     DOI: 10.1016/j.canlet.2016.01.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

Review 1.  Emerging role of lncRNAs in the normal and diseased intestinal barrier.

Authors:  Jie Chen; Jianhua Wan; Jianfang Ye; Liang Xia; Nonghua Lu
Journal:  Inflamm Res       Date:  2018-07-14       Impact factor: 4.575

2.  A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.

Authors:  Tian-Bao Huang; Chuan-Peng Dong; Guang-Chen Zhou; Sheng-Ming Lu; Yang Luan; Xiao Gu; Lei Liu; Xue-Fei Ding
Journal:  Int Urol Nephrol       Date:  2017-02-10       Impact factor: 2.370

3.  miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.

Authors:  Yunchuan Sun; Jianyong Zhao; Xiaoming Yin; Xiangkun Yuan; Jianfei Guo; Jianqiang Bi
Journal:  Cell Prolif       Date:  2016-08-24       Impact factor: 6.831

4.  Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.

Authors:  Gangling Tong; Xuan Wu; Boran Cheng; Liang Li; Xi Li; Zhu Li; Qiaohong Nong; Xiaoqiu Chen; Yajie Liu; Shubin Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 5.  Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.

Authors:  Vito Cucchiara; Joy C Yang; Vincenzo Mirone; Allen C Gao; Michael G Rosenfeld; Christopher P Evans
Journal:  Cancers (Basel)       Date:  2017-01-16       Impact factor: 6.639

6.  An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.

Authors:  Yingyi Zhang; Xinya Su; Zhe Kong; Fangqiu Fu; Pu Zhang; Dan Wang; Hai Wu; Xuechao Wan; Yao Li
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

Review 7.  Genomic Insight into the Role of lncRNA in Cancer Susceptibility.

Authors:  Ping Gao; Gong-Hong Wei
Journal:  Int J Mol Sci       Date:  2017-06-09       Impact factor: 5.923

8.  Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.

Authors:  Yang Jin; Zilian Cui; Xudong Li; Xunbo Jin; Jian Peng
Journal:  Oncotarget       Date:  2017-04-18

9.  Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers.

Authors:  Shangwei Ning; Yue Gao; Peng Wang; Xiang Li; Hui Zhi; Yan Zhang; Yue Liu; Jizhou Zhang; Maoni Guo; Dong Han; Xia Li
Journal:  Oncotarget       Date:  2016-07-19

Review 10.  Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.

Authors:  Richard Heery; Stephen P Finn; Sinead Cuffe; Steven G Gray
Journal:  Cancers (Basel)       Date:  2017-04-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.